Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2024.114210 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Amélie Anota und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France; Department of Human and Social Sciences, Centre Léon Bérard, Lyon, …. Hauptthemen laut MEDLINE: Quality of Life, Hodgkin Disease, Lymphoma, Non-Hodgkin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: French National Cancer Institute.
Abstract (Originalsprache)
INTRODUCTION: Considering the notable advances made in the treatment of lymphoma, assessment of health-related quality of life (HRQoL) of lymphoma patients has become a critical aspect to consider both in clinical research and routine practice. However, there is paucity of information about lymphoma specific HRQoL profile at diagnosis. PATIENTS AND METHODS: HRQoL at diagnosis was assessed for 3922 adult patients with newly diagnosed high-grade (HG) (n = 1994), low-grade (LG) (n = 1053) non-Hodgkin (NHL) and Hodgkin (HL) (n = 875) lymphomas included in REal world dAta in LYmphoma and Survival in Adults (REALYSA, NCT03869619), a prospective non-interventional multicentric cohort in France. Disease-specific HRQoL aspects were assessed with three validated EORTC questionnaires, namely, the QLQ-NHL-HG29, the QLQ-NHL-LG20 and the QLQ-HL27, for patients with NHL-HG, NHL-LG and HL, respectively. RESULTS: We confirmed the high-level of completion of these questionnaires in REALYSA cohort, ranging from 84 % for QLQ-HG29 to 88 % for QLQ-HL27. The proportion of patients with impaired global health status was as follows: T-cell NHL, 67 %; diffuse large B-cell (DLBCL), 62 %; Burkitt, 61 %; HL, 53 %; marginal zone, 49 %; mantle cell, 48 %; follicular, 47 %. Multivariable regression analyses for DLBCL, follicular and HL showed that gender, performance status and B symptoms were independently associated with all HRQoL dimensions. However, a variable effect of age and stage were observed among these three subtypes. CONCLUSIONS: A comprehensive analysis was made describing the HRQoL profile of newly diagnosed patients with different types of lymphomas. Our data may help to enhance the interpretation of HRQoL results in future studies using the recently validated EORTC lymphoma specific questionnaires.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France; Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; French National Platform Quality of Life and Cancer, Lyon, Fra…
- Department of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France.
- Department of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France; Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France.
- Hematology/Oncology, Université Paris Cité, Hôpital Saint Louis, Inserm U1153, Paris, France.
- Italian Group for Adult Hematologic Diseases (GIMEMA) Data Center and Health Outcomes Research Unit, Rome, Italy.
- Lymphoid Malignancies Unit, AP-HP, Henri Mondor University Hospital, Créteil, France.
Förderung
- French National Cancer Institute
Zitieren
APA
Anota, A., Basset, M., Charton, E., Bommier, C., Efficace, F., Dupuis, J., Cottone, F., Bouabdallah, K. K., Mollevi, C., Ysebaert, L., Winter, A., Bijou, F., Préau, M., Chauchet, A., Bernier, A., Fornecker, L. M., Hafirassou, H., Carras, S., Lachenal, F., …, & Ghesquières, H. (2024). Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114210
Vancouver
Anota A, Basset M, Charton E, Bommier C, Efficace F, Dupuis J, et al. Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114210
BibTeX
@article{Anota2024,
author = {Anota, Amélie and Basset, Mathurine and Charton, Emilie and Bommier, Côme and Efficace, Fabio and Dupuis, Jehan and Cottone, Francesco and Bouabdallah, Krimo K and Mollevi, Caroline and Ysebaert, Loïc and Winter, Audrey and Bijou, Fontanet and Préau, Marie and Chauchet, Adrien and Bernier, Adeline and Fornecker, Luc-Matthieu and Hafirassou, Hadia and Carras, Sylvain and Lachenal, Florence and Lionne-Huyghe, Pauline and Detourmignies, Laurence and Leyronnas, Cécile and Drénou, Bernard and Peyrou, Sandra Le Guyader and Abraham, Julie and Monnereau, Alain and Fouillet, Ludovic and Morschhauser, Franck and Rossi, Cédric and Belot, Aurélien and Ghesquières, Hervé},
title = {Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2024.114210}
}
EUVIMED